EligibleTrials

Alleviant ALLAY-HF Study

Recruiting · NCT05685303 · Interventional (participants receive a specific treatment) · Lead sponsor: Alleviant Medical, Inc.

View the official record on ClinicalTrials.gov →
Heart Failure

Interventions studied

Alleviant ALV1 SystemSham-Control

What this trial is about

Prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF.

Who can take part

Age range
40 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

60 locations listed across 27 US states.

Showing 60 of 93 listed sites. See the official record for the complete list.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.